1. Trivedi MH, et al. (2006). Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D Implications for Clinical Practice. Am J Psychiatry, 163(1):28-40
  2. Rush AJ, et. al. (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry, 163(11):1905-1917.
  3. Fava M, et. al. (2006) A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A Star*D Report. Am J Psychiatry, 163(7):1161-1172.
  4. McGrath PJ, et al. (2006) Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report. Am J Psychiatry, 163(9):1531-1541.
  5. NeuroStar Prescribing Information.
  6. Data on file. Neuronetics, Inc.
  7. Dunner DL, et al. (2014). A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation (TMS) for Patients with Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period. J Clin Psychiatry. 75(12):1394-1401. www.ncbi.nlm.nih.gov/pubmed/25271871
  8. Kessler, RC et al. (2005). Arch Gen Psychiatry, 62(6):593-602.
  9. Carpenter LL, et al. (2012). Transcranial Magnetic Stimulation (TMS) for Major Depression: A Multisite, Naturalistic, Observational Study of Acute Treatment Outcomes in Clinical Practice. Depression and Anxiety, 29(7):587-596. www.ncbi.nlm.nih.gov/pubmed/22689344
  10. George MS, et al. (2010). Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder: A Sham-Controlled Randomized Trial. Arch Gen Psychiatry, 67(5):507-516. www.ncbi.nlm.nih.gov/pubmed/20439832
  11. O’Reardon JP, et al. (2007). Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial. Biol Psychiatry, 62(11):1208-1216. www.ncbi.nlm.nih.gov/pubmed/17573044
  12. Janicak PG, et al. (2008). J Clin Psychiatry, 69(2):222-232.
  13. Janicak PG, et al. (2010). Durability of Clinical Benefit with Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Major Depression: Assessment of Relapse During a 6-Month, Multisite, Open-Label Study. Brain Stimulation, 3(4):187-199. www.ncbi.nlm.nih.gov/pubmed/20965447
  14. American Psychiatric Association (2010) (eds: Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS). Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 3rd Edition.
  15. World Health Organization. Depression Fact Sheet. http://www.who.int/mediacentre/factsheets/fs369/en/index.html. Accessed February 27, 2013.
  16. World Health Organization. The global burden of disease: 2004 update. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. Accessed March 12, 2013.
  17. World Health Organization. World Health Report: 2001: Mental Health: New Understanding, New Hope. www.who.int/whr/2001/en/whr01_en.pdf. Accessed March 12, 2013.
  18. National Institute of Mental Health. US Department of Health and Human Services. Depression. www.nimh.nih.gov/health/publications/depression/complete-index.shtml. Accessed April 24, 2013.
  19. ICD-10 classifications of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization. www.who.int/classifications/icd/en/bluebook.pdf. Accessed March 12, 2013.